α-Dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia

Diabetes Care

Volumn 24, Issue 4, 2001, Pages 726-732

  Beisswenger, Paul J ^a,b   Howell, Scott K ^b   O'Dell, Rita M ^a   Wood, Mary E ^a   Touchette, Allison D ^a   Szwergold, Benjamin S ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DICARBONYL DERIVATIVE; 3 DEOXYGLUCOSONE; ADVANCED GLYCATION END PRODUCT; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; LACTIC ACID; METHYLGLYOXAL;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; CROSSOVER PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCATION; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; MALE; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL; POSTPRANDIAL STATE; SELF MONITORING; TEST MEAL;

EID: 0034820785     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.4.726     Document Type: Article

References (57)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
2. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy
3. Evaluation of glycosylated hemoglobin in diabetic patients
4. Glycosylated serum proteins and glycosylated hemoglobin in the assessment of glycemic control in insulin-dependent and non-insulin-dependent diabetes mellitus
5. Clinical utility of nonenzymatically glycosylated blood: Proteins as an index of glucose control
6. A clinical approach for the diagnosis of diabetes mellitus: An analysis using glycosylated hemoglobin levels: Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels
7. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus: Multicenter Insulin Lispro Study Group
8. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment: Multicenter Insulin Lispro Study Group
9. The clinical information value of the glycosylated hemoglobin assay
10. Mortality and outcome of patients with brittle diabetes and recurrent ketoacidosis
11. Diabetic retinopathy: Assessment of severity and progression
12. Diabetic microangiopathy, genetics, environment, and treatment
13. Metabolism of fructose-3-phosphate in the diabetic rat lens
14. Identification of fructose 3-phosphate in the lens of diabetic rats
15. 3-Deoxyglucosone crosslinks proteins under physiologic conditions
16. Effect of methylglyoxal on protein thiol and amino groups in isolated rat enterocytes and activity of various brash border enzymes
17. A comparative study on proliferation, macromolecular synthesis, and energy metabolism of invitro grown Ehlrich ascites tumor cells in the presence of glucosone, galactosone and methylglyoxal
18. Suppression of cell-cycle progression during the S-phase of rat fibroblasts by 3-deoxyglucosone, a Maillard reaction intermediate
19. Detection of 3-deoxfructose and 3-deoxyglucosone: In human urine and plasma: Evidence for intermediate stages of the Maillard reaction in vivo
20. Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of the Maillard reaction, in diabetic serum
21. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications
22. Acetol production is increased in early diabetic nephropathy
23. Specificity of the chemical alteration in the diabetic glomerular basement membrane
24. Advanced glycosylation end products (AGEs) as early markers for diabetic retinopathy and nephropathy
25. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes
26. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy
27. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence
28. Improved mealtime treatment of diabetes mellitus using an insulin analogue: Multicenter Insulin Lispro Study Group
29. Comparative evaluation of three assay systems for automated determination of hemoglobin A1c
30. Quantitation of 3-deoxyglucosone levels in human plasma
31. Determination of methylglyoxal as the 2-methylquinoxaline by high-performance liquid chromatography and its application to biological samples
32. Sensitive determination of D-lactic acid in biological samples by high-performance liquid chromatography
33. Glucose intolerance and 23-year risk of coronary heart disease and total mortality: The Honolulu Heart Program
34. One-hour: Postload plasma glucose and risks of fatal coronary heart disease and stroke among nondiabetic men and women: The Chicago Heart Association Detection Project in Industry (CHA) Study
35. Risk factors for myocardial infarction and death in newly detected NIDDM: The Diabetes Intervention Study, 11-year follow-up
36. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial
37. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm
38. The role of 3-deoxyglucosone and the activity of its degradative pathways in the etiology of diabetic microvascular disease
39. Negative consequences of glycation
40. Pharmacology of methylglyoxal: Formation, modification of proteins and nucleic acids, and enzymatic detoxification: A role in pathogenesis and antiproliferative chemotherapy
41. Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes
42. The formation of methylglyoxal from triose phosphates: Investigation using a specific assay for methylglyoxal
43. Mechanism for the formation of methylglyoxal from triosephosphates
44. Formation of three-carbon sugar fragments at an early stage of the browing reaction of sugar with amines or amino acids
45. Formation of glycine and aminoacetone from L-threonine by rat liver mitochondria
46. The glyoxalase system: New developments towards functional characterization of a metabolic pathway fundamental to biological life
47. Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: Aldose reductase, glyoxalase I, and glyoxalase II: A clinical research center study
48. Modification of the glyoxalase system in streptozotocin-induced diabetic rats: Effect of the aldose reductase inhibitor Statil
49. Modification of the glyoxalase system in disease processes and prospects for therapeutic strategies
50. Impairment of glutathione metabolism in erythrocytes from patients with diabetes mellitus
51. Effect of insulin on impaired antioxidant activities in aortic endothelial cells from diabetic rabbits
52. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes
53. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis
54. Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase
55. Dietary glycotoxins: Inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration
56. Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy
57. Production and metabolism of 3-deoxyglucosone in humans